Literature DB >> 35999583

Correction to: Adherence and quality of life assessment in patients with asthma treatment with budesonide/formoterol via the Elpenhaler device: the COMPLETE study.

Konstantinos P Exarchos1, Nikoletta Rovina2, George Krommidas3, Dimitrios Latsios4, Athena Gogali5, Konstantinos Kostikas5.   

Abstract

Entities:  

Year:  2022        PMID: 35999583      PMCID: PMC9396767          DOI: 10.1186/s12890-022-02117-5

Source DB:  PubMed          Journal:  BMC Pulm Med        ISSN: 1471-2466            Impact factor:   3.320


× No keyword cloud information.

Correction to: BMC Pulmonary Medicine (2022) 22:254 10.1186/s12890-022-02049-0

Following publication of the article [1], the authors flagged that the following acknowledgement text had been erroneously omitted: "The MMAS-8 Scale, content, name, and trademarks are protected by US copyright and trademark laws. Permission for use of the scale and its coding is required. A license agreement is available from MMAR, LLC., www.moriskyscale.com." In addition, they highlighted that two references had been left out in error. The original article has since been updated with the acknowledgement text and the two references (references 20 and 21). The authors thank you for reading this erratum and apologize for any inconvenience caused.
  1 in total

1.  Adherence and quality of life assessment in patients with asthma treatment with budesonide/formoterol via the Elpenhaler device: the COMPLETE study.

Authors:  Konstantinos P Exarchos; Nikoletta Rovina; George Krommidas; Dimitrios Latsios; Athena Gogali; Konstantinos Kostikas
Journal:  BMC Pulm Med       Date:  2022-06-27       Impact factor: 3.320

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.